Paul Herendeen is EVP and CFO of Bausch Health Companies Inc.. Currently has a direct ownership of 386,618 shares of BHC, which is worth approximately $3.78 Million. The most recent transaction as insider was on Mar 10, 2021, when has been sold 59,519 shares (Common Shares, no par value) at a price of $32.97 per share, resulting in proceeds of $1,962,342. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 387K
0% 3M change
0% 12M change
Total Value Held $3.78 Million

Paul Herendeen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2021
SELL
Payment of exercise price or tax liability
$1,962,342 $32.97 p/Share
59,519 Reduced 13.34%
386,618 Common Shares, no par ...
Mar 08 2021
BUY
Grant, award, or other acquisition
-
50,518 Added 10.17%
446,137 Common Shares, no par ...
Mar 08 2021
BUY
Exercise of conversion of derivative security
-
49,324 Added 11.09%
395,619 Common Shares, no par ...
Mar 03 2021
BUY
Grant, award, or other acquisition
-
63,439 Added 15.48%
346,295 Common Shares, no par ...
Mar 01 2021
SELL
Payment of exercise price or tax liability
$495,022 $31.42 p/Share
15,755 Reduced 5.28%
282,856 Common Shares, no par ...

Also insider at

ELAN
Elanco Animal Health Inc Healthcare
PH

Paul Herendeen

EVP and CFO
Greenfield, IN

Track Institutional and Insider Activities on BHC

Follow Bausch Health Companies Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHC shares.

Notify only if

Insider Trading

Get notified when an Bausch Health Companies Inc. insider buys or sells BHC shares.

Notify only if

News

Receive news related to Bausch Health Companies Inc.

Track Activities on BHC